Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Trials & Filings in Brief: Sept. 26, 2013 | Contract Pharma

What are you searching for?

Sign in
Breaking News, Trials & Filings

Trials & Filings in Brief: Sept. 26, 2013

Dompe, Exelixis, Lilly, Lumena, NovaRx, ProMetic, Sarepta,

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Preclinical
ProMetic’s fibrosis candidate safe for trials . . . read more

Phase II
Positive results for Sarepta in DMD extension . . . read more

Lumena tests LUM001 in rare liver disease in children . . . read more

Phase II/III
Dompe to test Reparixin in autologous islet cell transplantation . . . read more

Phase III
Mixed results for Lilly . . . read more

Lucanix results miss endpoint in NSCLC . . . read more

Exelixis completes enrollment in mCRPC trial . . . read more

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics